ProMab Biotechnologies has developed a growing list of engineered cell lines including CAR-T/NK cells and target cells, e.g. cancer stem cells. Combining our antibody development and validation technologies, normal cells, iPSC’s, non-cancer stem cells, and cancer stem cells, will be examined to identify unique cancer stem cell markers. We also offer a full line of other CSC-products and services including cancer stem cell media, cancer stem cell antibodies, and more.
Features of the Novel CSC marker service:
- INTERNALIZATION ASSAY
- ANTIBODY SCREENING
- DRUG SENSITIVITY ASSAY
- MARKER IDENTIFICATION
- CSC ENRICHMENT
- EXPRESSION PROFILING
The service includes the cell culture of 10 cancer stem cell lines, transplantation of tumor cells in immunocompromised mice, generating recombinant protein, monoclonal antibodies, and extensive validation for $22,500.